PHGDH and acute myeloid leukemia: To assess whether interference with serine metabolism, potentiates the anti-AML activity of Rylaze, MOLM-14, and U937 PHGDH-knockout cell lines were treated with increasing doses of Rylaze (0-1 μg/mL).